An observational study in TG Index, TG/HDL-C Ratio and Young Population, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2025-08-19.
Sponsored by Assiut University · Observational
To evaluate the significance of the Triglyceride index and TG/HDL-C ratio as predictors of acute coronary syndromes in the young population
Cardiovascular disease (CVD) remains a major cause of morbidity and mortality worldwide, with a rising incidence of acute coronary syndromes (ACS) in young individuals under the age of 40. Early identification of at-risk individuals in this population is essential for implementing preventive strategies and reducing adverse outcomes【1,2】. Traditional risk factors such as hypertension, diabetes, smoking, and dyslipidemia are well-established; however, their predictive value in the young population is often limited【2】.
Recent studies have highlighted the significance of novel lipid-derived markers, particularly the triglyceride-glucose (TyG) index and the triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio, as potential predictors of insulin resistance, subclinical atherosclerosis, and cardiovascular events【1,3】. The TyG index and TG/HDL-C ratio are simple, cost-effective markers derived from routine laboratory parameters and have shown promising associations with metabolic syndrome, endothelial dysfunction, and coronary artery disease (CAD) severity【3,4】.
Despite emerging evidence in older adults, limited data exist regarding the utility of these markers in predicting ACS among the young population, where conventional risk scores often underestimate risk【4,5】. Early detection through these markers could improve risk stratification and guide preventive strategies.
This study aims to evaluate the significance of the TyG index and TG/HDL-C ratio as predictors of ACS in young adults, providing insight into their potential role in primary prevention
Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Young adult patients (18-45 years) admitted with acute coronary syndrome (STEMI, NSTEMI) who undergo coronary angiography during index hospitalization. Patients must have fasting lipid profile and fasting glucose measured within 24 hours of admission. Exclusions include familial hyperlipidemia, chronic inflammatory/autoimmune disease, severe renal or liver failure, active infection, recent use of non-statin lipid-altering drugs, or missing data for TyG/TG-HDL-C calculation. Follow-up will be conducted at 12 and 36 months to assess outcomes.
-
Age 18-40 years. Confirmed diagnosis of ACS (STEMI, NSTEMI). Willingness to participate with informed consent.
Exclusion Criteria:
Coronary angiography then SYNTAX score calculation
Predictive value of TyG index and TG/HDL-C ratio for acute coronary syndrome (ACS) in young adults
Occurrence of ACS (defined as STEMI, NSTEMI confirmed by clinical assessment, ECG changes, and cardiac biomarkers according to accepted guideline criteria) and the diagnostic/predictive performance of baseline Triglyceride-glucose (TyG) index and TG/HDL-C ratio for ACS.
Time frame: On second day of admission
No study locations are listed for this record.
Plan to share: Undecided
This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University